Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome

Figure 2

Visual change after treatment with autologous PRP eye drops in eyes presenting post-LASIK ocular surface syndrome and CDVA ≤ 0.9.